LGND Ligand Pharmaceuticals Incorpor
$284.47▼ -1.65%
Healthcare
Other
After hours
$284.47▲ +0.00%
Sep 11, 7:30 PM ET
Volume 261.2K
Avg Volume (10D) 190.8K
Key Metrics & Fundamentals
Market Cap
$5.67B
P/E Ratio
29.3
Div Yield
–%
52W Range
161.82 - 326.63
% vs 50 MA
-3.77%
% vs 200 MA
21.52%
RSI-14
45.9
MACD Histogram
+0.3900
Beta (1Y vs SPY)
0.80
Free Cash Flow
$21.35M
Gross Rev
$63.69M
Gross Profit
$60.48M
EBITDA
$26.79M
COGS
$3.21M
Operating Exp
$51.89M
Operating Income
$8.59M
EBIT
$8.59M
Pretax Income
$64.30M
Net Income
$48.51M
EPS (Diluted)
2.22
Price & Volume History
Loading chart…
Recent News
Ligand Pharmaceuticals Insider Sold Shares Worth $1,430,434, According to a Recent SEC Filing
MT Newswires · Sep 9, 2026 7:56 AM

Ligand Pharmaceuticals (LGND): Massive XOMA Acquisition Doubles The Royalty Book
Insider Monkey · Sep 4, 2026 10:44 AM

Ligand Pharmaceuticals Highlights XOMA-Fueled Royalty Growth, $700M in Deployable Capital
MarketBeat · Aug 26, 2026 5:02 PM

Ligand to Participate in September Investor Conferences
GlobeNewswire · Aug 26, 2026 11:00 AM

Breakout Watch: Savvy Investors Bet Millions On Royalty-Fueled Pharma Stock
Investor's Business Daily · Aug 14, 2026 8:02 PM

Ligand Pharmaceuticals (LGND) Stock Trades Below Fair Value Following A 337% Run
Simply Wall St. · Aug 14, 2026 11:11 AM

Ligand Pharmaceuticals (LGND) Reaffirms 2026 Guidance, Is The Stock Fully Priced?
Simply Wall St. · Aug 13, 2026 9:09 PM

Ligand (LGND) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 13, 2026 1:13 PM
Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates
GlobeNewswire · Aug 10, 2026 8:12 PM
LGND: XOMA Acquisition Closed
Zacks Small Cap Research · Aug 10, 2026 9:27 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See LGND's money flow as a full page
Social Sentiment
Avg +0.60 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.